C.M. Bidwell & Associates »

Crispr Therapeutics shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2023-09-30 $142k 3.1k 45.39
2023-06-30 $136k 2.4k 56.14
2023-03-31 $77k 1.7k 45.23
2022-12-31 $2.3k 56 40.64
2022-09-30 $1.0k 18 55.56
2022-06-30 $3.0k 53 56.60
2022-03-31 $3.0k 53 56.60
2021-12-31 $2.0k 25 80.00